Multi-marker Analysis of Anti-HBV Products Utilizing Primary Human Hepatocytes
Multi-marker Analysis of Anti-HBV Products Utilizing Primary Human Hepatocytes ImQuest BioSciences has developed and optimized a novel antiviral screening assay for hepatitis B virus (HBV) in primary human hepatocytes. This assay allows the simultaneous assessment of multiple markers of HBV replication, thus offering a unique method to assess both product efficacy and mechanism of action. […]
ImQuest Participates in International HBV Meeting
ImQuest Participates in International HBV Meeting Members of ImQuest BioSciences’ scientific team recently attended the International HBV Meeting in Paris, France. The annual meeting sponsored by the Hepatitis B Foundation, focused on the molecular biology of HBV and the development of novel treatment strategies to combat the virus to achieve the challenge of functional cure. […]
Combination Therapy Key to Fighting Bacterial Infections
Combination Therapy Key to Fighting Bacterial Infections A recent report in the scientific literature indicates that complex multi-drug combinations of antibiotics could be the key to fighting deadly bacteria. Current antibiotic treatments include using one or two drugs to fight an infection, and these treatments are becoming less and less effective as bacteria and other [...]
Critical need for novel antiviral drugs to combat both COVID and Influenza
Critical need for novel antiviral drugs to combat both COVID and Influenza Public health institutions throughout the United States are struggling to combat the concurrent spread of influenza and coronavirus as the global incidence increases into the fall and winter months. In the midst of a concurrent COVID pandemic, Officials at the CDC stress the […]
ImQuest BioSciences Chief Executive and Chief Scientific Offer named as one of Frederick County’s Top 50 CEOs.
ImQuest BioSciences Chief Executive and Chief Scientific Offer named as one of Frederick County’s Top 50 CEOs. The Frederick County Office of Economic Development has recently announced that our chief executive Robert Buckheit Jr. has been named as one of Frederick County’s Top 50 CEOs. Dr. Buckheit founded ImQuest in 2004 and has been the […]
Robert ‘Bobby’ Buckheit III has been recognized as one of Frederick’s Top 50 Professionals Under 40
Top 50 Frederick Robert ‘Bobby’ Buckheit III has been recognized as one of Frederick’s Top 50 Professionals Under 40 by the Frederick County Office of Economic Development in partnership with Frederick Magazine. Bobby is Director of Sales & Business Development and a Manager of Immunology and Flow Cytometry Services at ImQuest BioSciences Inc. During the […]
Coronavirus Drug Discovery and Development
Coronavirus Drug Discovery and Development As part of the international effort to slow and combat the spread of pandemic COVID-19, ImQuest BioSciences has testing capability to assess novel and repurposed antiviral therapeutic and prevention products for activity against coronaviruses. With BSL-2 and BSL-3 strains available for testing, with capacity for both targeted testing, range of action assessments, […]
Where Has Zika Gone?
Where Has Zika Gone? Although Zika virus (ZIKV) was isolated in 1947 in Uganda, the first major outbreak of ZIKV did not occur until 2007. This outbreak occurred outside of Africa, and it was reported that 73% of the residents of the Yap Islands were infected with ZIKV. In 2013 the virus spread throughout Cambodia, [...]